You are here: All Products  > ImmunoMet, a US HanAll Spinoff, Starts Clinical Trial of Cancer Drug

ImmunoMet, a US HanAll Spinoff, Starts Clinical Trial of Cancer Drug

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products